BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3693588)

  • 1. Phase I study of cefixime, a new oral cephalosporin.
    Nakashima M; Uematsu T; Takiguchi Y; Kanamaru M
    J Clin Pharmacol; 1987; 27(5):425-31. PubMed ID: 3693588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady state.
    Faulkner RD; Bohaychuk W; Desjardins RE; Look ZM; Haynes JD; Weiss AI; Silber BM
    J Clin Pharmacol; 1987 Oct; 27(10):807-12. PubMed ID: 3429686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent pharmacokinetics of a new oral cephalosporin, cefixime, in the dog.
    Bialer M; Batra VK; Morrison JA; Silber BM; Look ZM; Yacobi A
    Pharm Res; 1987 Feb; 4(1):33-7. PubMed ID: 3508527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profile of cefixime in man.
    Faulkner RD; Yacobi A; Barone JS; Kaplan SA; Silber BM
    Pediatr Infect Dis J; 1987 Oct; 6(10):963-70. PubMed ID: 3696837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute bioavailability of cefixime in man.
    Faulkner RD; Fernandez P; Lawrence G; Sia LL; Falkowski AJ; Weiss AI; Yacobi A; Silber BM
    J Clin Pharmacol; 1988 Aug; 28(8):700-6. PubMed ID: 3216036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetic and bactericidal characteristics of oral cefixime.
    Brittain DC; Scully BE; Hirose T; Neu HC
    Clin Pharmacol Ther; 1985 Nov; 38(5):590-4. PubMed ID: 4053491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of cefixime in bile, gallbladder wall and serum after preoperative administration in patients undergoing cholecystectomy.
    Moorthi K; Fleckenstein G; Nies B
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):287-90. PubMed ID: 2374476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of cefixime in patients with impaired renal function].
    Maeda H; Sako M; Fujii A; Yamazaki H; Kawabata G; Harada M; Arakawa S; Umezu K; Kamidono S; Ishigami J
    Jpn J Antibiot; 1986 Oct; 39(10):2716-20. PubMed ID: 3806957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on cefixime granules in the field of pediatrics].
    Haruta T; Kuroki S; Kobayashi Y
    Jpn J Antibiot; 1986 Apr; 39(4):1106-14. PubMed ID: 3761540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biliary excretion and hepatic disposal of cefixime: experimental and clinical study].
    Westphal JF; Brogard JM; Jehl F; Blickle JF; Dorner M; Monteil H
    Pathol Biol (Paris); 1992 May; 40(5):538-44. PubMed ID: 1495841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies of cefixime granules in pediatrics].
    Nakazawa S; Sato H; Narita A; Nakazawa S; Suzuki H; Matsumoto K; Chikaoka H; Kamigaki M; Koido R; Niino K
    Jpn J Antibiot; 1986 Apr; 39(4):1020-34. PubMed ID: 3761535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose.
    Mamzoridi K; Kasteridou N; Peonides A; Niopas I
    Pharmacol Toxicol; 1996 Jun; 78(6):417-20. PubMed ID: 8829204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of cefixime in the fasted and fed state.
    Faulkner RD; Bohaychuk W; Haynes JD; Desjardins RE; Yacobi A; Silber BM
    Eur J Clin Pharmacol; 1988; 34(5):525-8. PubMed ID: 3203716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and clinical effects of cefixime in pediatrics].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita S; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Nagayama K
    Jpn J Antibiot; 1986 Apr; 39(4):1177-200. PubMed ID: 3761546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of cefixime in unweaned calves.
    Ziv G; Lavy E; Glickman A; Winkler M
    J Vet Pharmacol Ther; 1995 Apr; 18(2):94-100. PubMed ID: 7629935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of cefixime in healthy volunteers after a single oral administration of 200 mg].
    Montay G; Le Liboux A; Thebault JJ; Roche G; Frydman A; Gaillot J
    Presse Med; 1989 Oct; 18(32):1583-6. PubMed ID: 2530537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
    Nix DE; Symonds WT; Hyatt JM; Wilton JH; Teal MA; Reidenberg P; Affrime MB
    Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefixime in the young and elderly.
    Faulkner RD; Bohaychuk W; Lanc RA; Haynes JD; Desjardins RE; Yacobi A; Silber BM
    J Antimicrob Chemother; 1988 Jun; 21(6):787-94. PubMed ID: 3410802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefixime penetration in human renal parenchyma.
    Leroy A; Oser B; Grise P; Humbert G
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1240-2. PubMed ID: 7574508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.